Spinal Metastases from Colorectal Cancer at Mass General Brigham: A Twenty-Year Case Series With Literature Review

• Published in: World neurosurgery Vol. 176; pp. e246 - e253
• Main Authors: Yearley, Alexander G., McNulty, Jack J., Chalif, Eric J., Chalif, Joshua I., Lee, Suk Joon, Klinger, Neil V., Zaidi, Hasan A.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.08.2023
• Subjects: Case series; Colorectal cancer; Colorectal Neoplasms - surgery; Humans; Middle Aged; Neurosurgery; Quality of Life; Retrospective Studies; Spinal metastasis; Spinal Neoplasms - secondary; Spinal Neoplasms - therapy; Treatment Outcome; Spinal metastasis; RT; OS; Tx; Colorectal cancer; Case series; Neurosurgery; IQR; KPS; mRS; UE; SD; Dx; CRC; LE
• DOI: 10.1016/j.wneu.2023.05.045
• ISSN: 1878-8750; 1878-8769

We present an institutional case series of patients treated for colorectal carcinoma (CRC) spinal metastases to investigate the outcomes between no treatment, radiation, surgery, and surgery/radiation. A retrospective cohort of patients with CRC spinal metastases presenting to affiliated institutions between 2001 and 2021 wereidentified. Information related to patient demographics, treatment modality, treatment outcomes, symptom improvement, and survival was collected by chart review. Overall survival (OS) was compared between treatments by log-rank significance testing. A literature review was conducted to identify other cases series of CRC patients with spinal metastases. Eighty-nine patients (mean age 58.5) with CRC spinal metastases across a mean of 3.3 levels met inclusion criteria: 14 (15.7%) received no treatment, 11 (12.4%) received surgery alone, 37 (41.6%) received radiation alone, and 27 (30.3%) received both radiation and surgery. Patients treated with combination therapy had the longest median OS of 24.7 months (range 0.6–85.9), which did not significantly differ from the median OS of 8.9 months (range 0.2–42.6) observed in patients who received no treatment (P = 0.075). Combination therapy provided objectively longer survival time in comparison to other treatment modalities but failed to reach statistical significance. The majority of patients that received treatment (n = 51/75, 68.0%) experienced some degree of symptomatic or functional improvement. Therapeutic intervention has the potential to improve the quality of life in patients with CRC spinal metastases. We demonstrate that surgery and radiation are useful options for these patients, despite their lack of objective improvement in OS.